Viewing Study NCT03869632


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-01-14 @ 6:19 PM
Study NCT ID: NCT03869632
Status: UNKNOWN
Last Update Posted: 2021-11-16
First Post: 2019-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None YL-13027 View
None Advanced Solid Tumors View